Horizon 2020 MSCA-ITN-ETN European Training Networks: Pharma and biotechnological industrial partners sought for a MSCA-ITN-ETN proposal

REQUEST from Hungary, reference: RDHU20180906001, valid from 06-09-2018 untill 30-11-2018

Research & Development
  • Start date:
    6 september 2018
  • End date:
    30 november 2018
  • Summary:
    A Hungarian research and technology organization (RTO) is looking for partners from pharma and biotechnological industry to join a H2020 MSCA-ITN-ETN European Training Networks proposal. The proposal will set out a training network including experts from both academic and private enterprises, addressing the various aspects of non-natural peptidic compounds.
  • Description:
    The task of the Hungarian RTO is to explore new functional and structural materials and related chemical technologies in the fields of sustainable environment and sustainable health. In the second field, focus is on soft materials important in medical biology, drug carriers, biosensors, and processes taking place in them.

    The synergy of their widespread expertise helps to work out interdisciplinary research issues. By answering basic research questions, their research projects are aiming at solving certain social – economic – environmental problems.

    The outlined research field is closely related to research actively performed already by the participants of the constellation. Some of the supportive results are fully available via publications. The project proposal aims to deeper the complementary understanding in related areas as well as reach prototype molecular scaffolds ready for specific pharmaceutical-biotechnological developments.

    The consortium would like to apply for H2020 MSCA-ITN-ETN call in January 2019 and they wish to find further partners.

    They are looking for partners from the areas of expertise listed below:
    Bacterial test
    Oncological test
    Protein engineering
    Peptide sequences
    Trans-bilayer transportation
    Pharmacological investigation

    The optimal partner should provide complementary expertise in the outlined field, potentially in testing either pharmaceutical or biomedical applicability of the compounds developed.

    Recruitment/fellowship duration: 3-36 months
    Deadline for call: 15 January 2019
    Deadline for EOI: 30 November 2018
Partner Sought
  • Type of Partnership Considered:
    Research cooperation agreement
  • Technical Specification or Expertise Sought:

    To strengthen the consortium the RTO is looking for SMEs or large enterprises (LEs) from Europe: biotechnological SMEs focusing on pharmacological investigation capable of performing diverse protein engineering tasks or LE from Europe (no restrictions apply): interested in development of peptide-based bioactive compounds.

    SME 11-50,SME <10,>500 MNE,251-500,SME 51-250,>500

  • Development stage:
    Proposal under development
  • IPR Status:
  • Market keywords:
    Biochemistry / Biophysics
    Molecular design
    Other medical imaging
    Drug delivery and other equipment
  • Technology keywords:
    Computational Chemistry and Modelling
    Organic Chemistry
    Biochemistry / Biophysics
  • NACE keywords:
  • Advantages and Innovations:
    The project will aim to reach, by design and investigation, peptidic compounds offering higher selectivity and higher affinity in peptide-protein or peptide-biomembrane interactions, improved metabolic stability, and slower clearance (via efflux).
  • Type and Size of Organisation:
    R&D Institution
  • Already Engaged in Trans-National Cooperation
  • Year Established:
  • Turnover:
  • Country of origin:
  • Languages spoken
    • English
    • Hungarian
    • Swedish
    • German
    • Russian